Stay updated on Durvalumab Safety Post Chemo Radiation in Stage III NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab Safety Post Chemo Radiation in Stage III NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab Safety Post Chemo Radiation in Stage III NSCLC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 in the page history.
    Difference
    0.1%
    Check dated 2026-03-07T04:43:47.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    A new revision v3.4.2 was added to the history, replacing the previous v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-13T13:41:29.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1 in the page history; no visible changes to study details or content.
    Difference
    0.1%
    Check dated 2026-02-06T09:10:06.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 and removed Revision: v3.3.3 from the page's revision history.
    Difference
    0.1%
    Check dated 2026-01-15T04:47:08.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Revision: v3.3.3 has been added to the history, and HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed from the page footer. These updates reflect minor metadata changes to the page's revision history.
    Difference
    0.1%
    Check dated 2025-12-24T14:54:57.000Z thumbnail image
  8. Check
    109 days ago
    Change Detected
    Summary
    Revision: v3.3.2 appears as the site revision tag, replacing v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T13:55:29.000Z thumbnail image

Stay in the know with updates to Durvalumab Safety Post Chemo Radiation in Stage III NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab Safety Post Chemo Radiation in Stage III NSCLC Clinical Trial page.